Ireland is the latest country to put its name forward to host the European Medicines Agency (EMA), should it be relocated following the UK’s Brexit vote.
Spain, Sweden, Denmark and Italy are among the other countries to have expressed interest in hosting the Agency, and the Irish Health Minister Simon Harris confirmed that his government would be bidding to attract the EMA to Dublin on Thursday.
Mr Harris argued that a move across the Irish Sea would keep disruption to a minimum, and said that the excellent track record of the country’s Health Products Regulatory Authority (HPRA) and the part already played by many of its members on EMA committees, further strengthened his country’s case.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze